Description

Clinical Evidence

• Animal studies show significant improvements in wound healing and tissue regeneration, particularly in musculoskeletal injuries.
• TB-500 has been observed to upregulate actin (a key protein for cell movement and healing), which helps facilitate tissue remodeling.
• In cardiac models, TB-500 has demonstrated potential for heart repair post-infarction, though further research is required.
• Neuroprotective and corneal healing properties have also been observed in rodent and rabbit models.
Note: TB-500 remains under investigation and is not approved for clinical use in humans.

Potential Side Effects

TB-500 is generally well tolerated in preclinical studies. However, possible side effects based on anecdotal and animal research include:
• Mild fatigue
• Temporary lethargy or dizziness
• Injection site redness or irritation
• Unintended tissue growth (hypothetical risk due to angiogenesis)
No serious adverse effects have been consistently reported in preclinical studies, though long-term safety in humans is unknown.

Disclaimer

This peptide is for research purposes only and is not approved for human or veterinary use. It should be handled only by qualified professionals in a controlled laboratory setting. All references to benefits are based solely on preclinical and in vivo animal studies.